13:57 EDT DEPO Depomed retreats after FDA panel votes against approving drug
Subscribe for More Information
13:54 EDT DEPO Depomed resumes trading, down 9.8% after FDA advisors vote against drug approval
13:38 EDT DEPO Depomed says will cease all spending related to Sefelsa following FDA meeting
Subscribe for More Information
13:37 EDT DEPO Depomed to resume trading at 13:50 ET
Quotes resume at 13:45 ET.
13:33 EDT DEPO Depomed provides update on Sefelsa FDA advisory committee
Subscribe for More Information
12:44 EDT DEPO Depomed's proposed menopause treatment rejected by FDA panel, WSJ says
Subscribe for More Information
11:40 EDT DEPO FDA panel says Depomed menopause drug ineffective, DJ reports
Subscribe for More Information
07:41 EDT DEPO FDA's Reproductive Health Drugs Advisory Committee to hold a meeting
The Committee discusses Depomed's New Drug Application for Serada(r). Serada is Depomed's proprietary extended release formulation of Gabapentin in development for treatment of menopausal hot flashes. The meeting is being held at FDA offices in Silver Spring, Maryland on March 4 at 8 am. Webcast Link
07:01 EDT DEPO Depomed trading halted, news pending
Subscribe for More Information
FEATURED North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM